全文获取类型
收费全文 | 37331篇 |
免费 | 3469篇 |
国内免费 | 1855篇 |
专业分类
耳鼻咽喉 | 338篇 |
儿科学 | 399篇 |
妇产科学 | 588篇 |
基础医学 | 7328篇 |
口腔科学 | 809篇 |
临床医学 | 2000篇 |
内科学 | 4917篇 |
皮肤病学 | 702篇 |
神经病学 | 1932篇 |
特种医学 | 739篇 |
外国民族医学 | 20篇 |
外科学 | 2263篇 |
综合类 | 5604篇 |
现状与发展 | 8篇 |
预防医学 | 1160篇 |
眼科学 | 567篇 |
药学 | 4533篇 |
8篇 | |
中国医学 | 1108篇 |
肿瘤学 | 7632篇 |
出版年
2024年 | 93篇 |
2023年 | 492篇 |
2022年 | 1026篇 |
2021年 | 1321篇 |
2020年 | 1127篇 |
2019年 | 951篇 |
2018年 | 911篇 |
2017年 | 957篇 |
2016年 | 1014篇 |
2015年 | 1336篇 |
2014年 | 1966篇 |
2013年 | 2106篇 |
2012年 | 1895篇 |
2011年 | 2355篇 |
2010年 | 1951篇 |
2009年 | 2062篇 |
2008年 | 2159篇 |
2007年 | 2127篇 |
2006年 | 1924篇 |
2005年 | 1872篇 |
2004年 | 1727篇 |
2003年 | 1664篇 |
2002年 | 1429篇 |
2001年 | 1299篇 |
2000年 | 1143篇 |
1999年 | 945篇 |
1998年 | 842篇 |
1997年 | 699篇 |
1996年 | 598篇 |
1995年 | 479篇 |
1994年 | 321篇 |
1993年 | 289篇 |
1992年 | 183篇 |
1991年 | 148篇 |
1990年 | 101篇 |
1989年 | 100篇 |
1988年 | 98篇 |
1987年 | 79篇 |
1986年 | 82篇 |
1985年 | 109篇 |
1984年 | 120篇 |
1983年 | 63篇 |
1982年 | 84篇 |
1981年 | 67篇 |
1980年 | 71篇 |
1979年 | 54篇 |
1978年 | 41篇 |
1977年 | 46篇 |
1976年 | 38篇 |
1973年 | 19篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Osric A. Forrest Daniel M. Chopyk Yael Gernez Milton R. Brown Carol K. Conrad Richard B. Moss Vin Tangpricha Limin Peng Rabindra Tirouvanziam 《Journal of cystic fibrosis》2019,18(1):64-70
Background
Resistin is an immunometabolic mediator that is elevated in several inflammatory disorders. A ligand for Toll-like receptor 4, resistin modulates the recruitment and activation of myeloid cells, notably neutrophils. Neutrophils are major drivers of cystic fibrosis (CF) lung disease, in part due to the release of human neutrophil elastase- and myeloperoxidase-rich primary granules, leading to tissue damage. Here we assessed the relationship of resistin to CF lung disease.Methods
Resistin levels were measured in plasma and sputum from three retrospective CF cohorts spanning a wide range of disease. We also assessed the ability of neutrophils to secrete resistin upon activation in vitro. Finally, we constructed a multivariate model assessing the relationship between resistin levels and lung function.Results
Plasma resistin levels were only marginally higher in CF than in healthy control subjects. By contrast, sputum resistin levels were very high in CF, reaching 50–100 fold higher levels than in plasma. Among CF patients, higher plasma resistin levels were associated with allergic bronchopulmonary aspergillosis, and higher sputum resistin levels were associated with CF-related diabetes. Mechanistically, in vitro release of neutrophil primary granules was concomitant with resistin secretion. Overall, sputum resistin levels were negatively correlated with CF lung function, independently of other variables (age, sex, and genotype).Conclusions
Our data establish relationships between resistin levels in the plasma and sputum of CF patients that correlate with disease status, and identify resistin as a novel mechanistic link between neutrophilic inflammation and lung disease in CF. 相似文献2.
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features
下载免费PDF全文
![点击此处可从《Histopathology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
3.
4.
《Drug discovery today》2022,27(6):1733-1742
Compounds that exhibit assay interference or undesirable mechanisms of bioactivity are routinely encountered in assays at various stages of drug discovery. We observed that assays for the investigation of thiol-reactive and redox-active compounds have not been collected in a comprehensive review. Here, we review these assays and subject them to experimental optimization to improve their reliability. We demonstrate the usefulness of our assay cascade by assaying a library of bioactive compounds, chemical probes, and a set of approved drugs. These high-throughput assays should complement the array of wet-lab and in silico assays during the initial stages of hit discovery campaigns to pursue only hit compounds with tractable mechanisms of action. 相似文献
6.
7.
8.
9.
10.
Zheyuan Wang Zhiheng Shi Lu Zhang Huihan Zhang Yawu Zhang 《Pathology, research and practice》2019,215(3):499-505
Profilin 1 (PFN1) is a critical actin-regulatory protein; however, its functional role in hepatocellular carcinoma (HCC) progression remains to be further elucidated. In the present study, we observed that the expression levels of PFN1 were significantly decreased in HCC tissues and cell lines. Low PFN1 expression was significantly correlated with aggressive clinicopathological characteristics and poor prognosis of HCC patients. Further in vitro experiments demonstrated that overexpression of PFN1 remarkably inhibited the proliferation, migration, invasion and EMT of HCC cells. Moreover, we also found that PFN1 was a direct target gene of miR-19a-3p, and in HCC tissues, and there was a significantly inverse correlation between PFN1 mRNA and miR-19a-3p expression. Collectively, our results showed that PFN1 functions as a tumor suppressor in HCC, and might serve as a diagnostic and therapeutic target for HCC patients. 相似文献